If you have been reading about ghrelin receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Reported for the free peptide |
| Molecular mass | 711.85 Da | Monoisotopic value |
| Residue motif | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | Non-natural residues at positions one and three |
| Primary target | GHSR-1a | Ghrelin receptor, G protein coupled |
| Reported plasma half-life | About two hours | Values vary with assay and subject group |
The molecule contains five residues, including alpha-aminoisobutyric acid, D-2-naphthylalanine, and D-phenylalanine, and it ends in a lysine amide. Non-natural and D-configured residues make the chain less susceptible to common peptidases, which helps explain its resistance to rapid breakdown. Its molecular formula is C38H49N9O5, corresponding to a free-base mass near 711.9 daltons. The C-terminal amide removes a negative charge and is a recurring feature in receptor-active peptides of this family. These structural choices are usually discussed as the basis for its selectivity profile.
Published animal and early human work describes growth hormone release that is separated from comparable rises in adrenocorticotropic hormone and cortisol. Prolactin changes are reported as small in the same studies. Selectivity is attributed to binding at the ghrelin receptor and to the downstream signaling that follows, rather than to differences in how quickly the peptide is cleared. Authors commonly label the compound selective rather than potent, because the same mass produces a smaller growth hormone response than some older secretagogues tested in parallel. Whether that profile holds across species and routes of administration remains an open question.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, a structure that differs from natural ghrelin in length and in the presence of non-natural amino acid residues. Early laboratory work described it as a comparatively selective agent that stimulates growth hormone release with limited effect on other pituitary hormones. The compound is supplied as a lyophilized solid for research use and has no identified natural source in the body.
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
Bioadhesives inspired by gastropods are biomimetic adhesive materials modeled on the mucus of gastropods such as snails and slugs. Gastropod mucus is a viscoelastic secretion containing glycoproteins, glycosaminoglycans, enzymes, and metal ions, and can adhere to wet surfaces. Gastropod-inspired adhesives reproduce aspects of this adhesion through chemical bonding, mechanical interlocking, electrostatic interactions, and cross-linking. Energy-dissipating polymer networks can contribute to their mechanical strength and toughness. Research on gastropod-inspired bioadhesives has focused particularly on biomedical applications, including wound closure, tissue sealing, drug delivery, dental applications, and the attachment of medical devices. Experimental systems include hydrogel adhesives designed to maintain adhesion to wet and moving biological tissues, and some have also been studied for antimicrobial activity and biocompatibility.
British Post Office scandal: Court documents reveal that Fujitsu, the company at the centre of the Post Office scandal, won a £184m contract by the Foreign and Commonwealth Office in 2021, despite concerns the system it was offering was "unfit for purpose". Court documents show that former prime minister Sir Tony Blair was warned the Horizon IT system could be "possibly unreliable" before it was rolled out, and raised concerns about it, but gave it the green light after receiving reassurance from others, including his Secretary of State for Trade and Industry Peter Mandelson. 13 January – Yvonne Tracey, a former deputy postmistress from New Malden, south London, announces her intention to stand in the Parliamentary constituency of Kingston and Surbiton, Sir Ed Davey's seat, at the next general election. 14 January – Foreign Secretary David Cameron tells the BBC that military action was taken against Houthi rebels because the strikes were needed after months of attacks against cargo ships, and that the UK is "prepared to back our words with actions". 15 January – Sunak tells Parliament that air strikes against Houthi targets were meant as a "limited, single action" but that the UK "will not hesitate to protect our security, our people and our interests where required". James Stockan announces he is stepping down from the post of leader of Orkney Islands Council, as well as relinquishing his council seat, after six years in the role.
the carboxylation of glutamate allows for better binding of calcium cations, Hydroxyproline, generated by hydroxylation of proline, is a major component of the connective tissue collagen. Hypusine in the translation initiation factor EIF5A, contains a modification of lysine. Some non-proteinogenic amino acids are not found in proteins. Examples include 2-aminoisobutyric acid and the neurotransmitter gamma-aminobutyric acid. Non-proteinogenic amino acids often occur as intermediates in the metabolic pathways for standard amino acids – for example, ornithine and citrulline occur in the urea cycle, part of amino acid catabolism (see below). A rare exception to the dominance of α-amino acids in biology is the β-amino acid beta alanine (3-aminopropanoic acid), which is used in plants and microorganisms in the synthesis of pantothenic acid (vitamin B5), a component of coenzyme A.
== Production == 60Co does not occur naturally on Earth in significant amounts, so 60Co is synthesized by bombarding a 59Co target with a thermal neutron source - in a commercial or industrial context, that means a nuclear reactor. The CANDU reactors can be used to activate 59Co, by substituting the control rods with cobalt rods. In the United States, as of 2010, it is being produced in a boiling water reactor at Hope Creek Nuclear Generating Station. The cobalt targets are substituted here for a small number of fuel assemblies. Still, over 40% of all single-use medical devices are sterilized using 60Co from Bruce nuclear generating station. The reaction in all cases is
== Adverse effects == Genital infections seem to be the most common adverse effect of gliflozins. In clinical trials fungal infections, urinary tract infections and osmotic diuresis were higher in patients treated with gliflozins. In May 2015, the FDA issued a warning that gliflozins can increase risk of diabetic ketoacidosis (DKA, a serious condition in which the body produces high levels of blood acids called ketones). By reducing glucose blood circulation, gliflozins cause less stimulation of endogenous insulin secretion or lower dose of exogenous insulin that results in diabetic ketoacidosis. They can specifically cause euglycemic DKA (euDKA, DKA where the blood sugar is not elevated) because of the renal tubular absorption of ketone bodies. A particularly high risk period for ketoacidosis is the perioperative period. SGLT2 inhibitors may need to be discontinued before surgery, and are only recommended when someone is not unwell, is adequately hydrated, and can consume a regular diet. Symptoms of ketoacidosis include nausea, vomiting, abdominal pain, tiredness, and trouble breathing. To lessen the risk of developing ketoacidosis after surgery, the FDA has approved changes to the prescribing information for SGLT2 inhibitor diabetes medicines to recommend they be stopped temporarily before scheduled surgery. Canagliflozin, dapagliflozin, and empagliflozin should each be stopped at least three days before, and ertugliflozin should be stopped at least four days before scheduled surgery.
Sources: en.wikipedia.org
Most corps have one. In general, western provinces with large non-Han population have more than those in China's interior. Corps are further subdivided at lower administrative levels. Regimental-level detachments (Chinese: 支队; pinyin: zhīduì) are found in provinces, prefectures, and specifically designated cities. Battalions (Chinese: 大队; pinyin: dadui) are located in districts of the important cities and counties. Companies (Chinese: 中队; pinyin: zhōngduì) are found in counties. All corps have subordinate elementary command colleges.
== Corporate history == KCI was founded in 1976 in San Antonio, Texas, by James R. Leininger, then an emergency room physician who wanted to help prevent the pulmonary complications associated with immobility. Over time, the company developed or acquired a line of therapeutic specialty beds, introducing a specialty bed for acute care patients with pulmonary complications. Initially KCI's product development focused on therapeutic beds and surfaces then expanded to introduce the first commercial negative pressure wound therapy products in the mid-1990s. KCI acquired regenerative medicine company, LifeCell, in 2008 in a non-hostile transaction for US$1.7 billion. In January 2012, LifeCell was made a sister company to KCI. In 2013, LifeCell and KCI recombined into one company.
Campylobacter jejuni which can lead to secondary Guillain–Barré syndrome and periodontitis Clostridium perfringens, the "cafeteria germ" Salmonella spp. – its S. typhimurium infection is caused by consumption of eggs or poultry that are not adequately cooked or by other interactive human-animal pathogens Escherichia coli O157:H7 enterohemorrhagic (EHEC) which can cause hemolytic-uremic syndrome Other common bacterial foodborne pathogens are:
==== Philippines ==== In the Philippines, the sweet delicacy tahô is made of fresh tofu (vendors scooped from a wooden bucket with a flat spoon) with brown palm or pandan-flavored sugar syrup and sagó.
== Births == 13 December - Robert Griffiths, inventor (died 1883) 19 December - John David Edwards, hymn-writer (died 1885) date unknown Evan Davies, missionary (died 1864) Hugh Hughes (Tegai), writer (died 1864) John William Thomas, mathematician (died 1840)
Sources: en.wikipedia.org
=== For evaluative well-being (life satisfaction) === Mental health is the strongest individual predictor of life satisfaction. Mental illness is associated with poorer well-being. In fact, mental health is the strongest determinant of quality of life at a later age. Studies have documented the relationship between anxiety and quality of life. The VOXEU analysis of happiness showed the principal determinants of an adult's life satisfaction to be income, parenting, family break up, mother's mental health and schooling. The factors that explain life satisfaction roughly map (negatively) to those factors that explain misery. They are first and foremost diagnosed depression/anxiety, which explains twice as much as the next factor, physical health (number of medical conditions), that explains just as much variance in subjective well-being between people, as income and whether someone is partnered. These factors count twice as much as each of whether someone is employed and whether they are a non-criminal, which in turn are 3 times as important as years of education. Overall, the best predictor of an adult's life satisfaction is their emotional health as a child as reported by the mother and child. It trumps factors like the qualifications that someone gets and their behaviour at 16 as reported by the mother. A child and therefore an adult's emotional health is most affected itself by a mother's mental health, which is just over twice as important as family income.
This enhances the investigative capabilities of the CPT on isotopes around the N=Z line with particular emphasis on isotopes of interest to low-energy tests of the electroweak interaction and the rp-process.
Observers noted that thallus form—crusty, leafy, or shrubby—could vary within a lineage under different environments or slight genetic shifts. By contrast, spore traits and thecium structure stayed constant and resisted ecological plasticity. Watson (1929) argued that reproductive parts deserve priority: they belong solely to the fungus, whereas thallus form—shaped by both partners—can mislead. Field keys of the era highlighted spore colour (hyaline vs. brown), septation (simple, muriform, etc.), ascus type, and chemical spot tests to sort genera and families. Thallus form still appeared, but only as a secondary cue once the "primary" traits had fixed a specimen's position. This fungal focus flowed directly from the dual hypothesis: lichens were now viewed as fungi first. Accepting lichens as fungi raised a nomenclatural riddle: does the word "lichen" refer to the whole consortium or only to the fungal partner? In 1913 Bruce Fink declared that "the lichen is a fungus pure and simple", framing the issue in stark terms. A more radical solution arrived in the 1950s when Raffaele Ciferri and Ruggero Tomaselli proposed parallel names for the cultured fungal partner, adding the suffix ‑myces (e.g. Cladoniomyces for the Cladonia mycobiont). Their scheme ran straight into the newly adopted Stockholm Code (1952), which already covered lichens under the International Code of Botanical Nomenclature, and the –myces names were soon ruled illegitimate.
The density of francium is expected to be around 2.48 g/cm3 (Mendeleev's method extrapolates 2.4 g/cm3). Another calculation gives a much higher value of 3.57 g/cm3. Francium is predicted to have a bulk modulus of 2.1–2.6 GPa. Linus Pauling estimated the electronegativity of francium at 0.7 on the Pauling scale, the same as caesium; the value for caesium has since been refined to 0.79, but there are no experimental data to allow a refinement of the value for francium. Francium has a slightly higher ionization energy than caesium, 392.811(4) kJ/mol as opposed to 375.7041(2) kJ/mol for caesium, as would be expected from relativistic effects, and this would imply that caesium is the less electronegative of the two. Francium should also have a higher electron affinity than caesium and the Fr− ion should be more polarizable than the Cs− ion.
== External links == Granulocyte+Colony-Stimulating+Factor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: P09919 (Granulocyte colony-stimulating factor) at the PDBe-KB.
Sources: en.wikipedia.org
Both molecules activate the same receptor, GHSR-1a, but they share little sequence identity. Ghrelin is a 28-amino-acid hormone carrying a distinctive acyl modification, whereas ipamorelin is a short synthetic peptide. The shared target explains overlapping endocrine effects, while the different structures account for differences in metabolic stability and receptor selectivity.
Early animal and human studies reported growth hormone release at levels that produced small changes in cortisol, prolactin and adrenocorticotropic hormone. That contrast with older secretagogues gave rise to the selectivity label. The observation is consistent across several reports but rests on a limited number of small studies.
Plasma peptidases cleave the molecule into smaller fragments, and reported half-lives in human studies are on the order of a couple of hours. The identity and activity of individual breakdown products have not been fully mapped. Questions about tissue-level clearance remain open.
It acts on the growth hormone secretagogue receptor, GHS-R1a, which is also the receptor for ghrelin. Binding triggers intracellular signaling that promotes growth hormone release from the pituitary. The interaction is the basis for its classification as a secretagogue.